LUGPA MolDx® Update 

Webinar Recording Now Available  

Recently, certain Medicare jurisdictions that participate in the MolDx® program instituted a policy in which labs that wish to perform molecular syndromic testing for infectious disease must register with the MolDx® program.  LUGPA is aware that many member practices that wish to perform these important tests have had issues with the process and have been unable to successfully complete the MolDx® registration requirements.

While LUGPA cannot act directly to promote the financial interests of any individual member practice, as a service to its member practices, LUGPA has retained the services of Michael Barlow, who served as the Palmetto GBA MolDX® program developer and executive to help LUGPA members understand the submission process. 

We invite you to join a 60-minute informational webinar with Mr. Barlow, moderated by Dr. Deepak A. Kapoor, LUGPA Health Policy Chair.  A recording of the webinar, which was held was held August 4, 2022, is now available on LUGPA's Presentation Archive page (login required).

The webinar includes:

• The MolDx submission process in brief
• The current MolDx position with respect to molecular testing for syndromic infectious disease testing
• LUGPA’s plan of action to conduct clinical utility research on molecular syndromic testing

Join us for this important informational presentation to help LUGPA members continue to provide vital services to their patients.